GEP20125531B - Reconstituted surfactants having improved properties - Google Patents

Reconstituted surfactants having improved properties

Info

Publication number: GEP20125531B
Authority: GE; Georgia
Prior art keywords: surfactant; improved properties; reconstituted surfactants; reconstituted; native
Prior art date: 2006-10-13

Application number

GEAP200711224A

Other languages

English (en)

Inventor

Farmaceutici S P A Chiesi

Original Assignee

Chiesi Farma Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-13

Filing date

2007-09-28

Publication date

2012-05-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39079026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GEP20125531(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-09-28 Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa

2012-05-25 Publication of GEP20125531B publication Critical patent/GEP20125531B/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Biophysics (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Fire-Extinguishing Compositions (AREA)
Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)

GEAP200711224A 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties GEP20125531B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP06021521		2006-10-13

Publications (1)

Publication Number	Publication Date
GEP20125531B true GEP20125531B (en)	2012-05-25

Family

ID=39079026

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GEAP200711224A GEP20125531B (en)	2006-10-13	2007-09-28	Reconstituted surfactants having improved properties

Country Status (35)

Country	Link
US (2)	US8183210B2 (sr)
EP (1)	EP2078038B1 (sr)
JP (2)	JP5405307B2 (sr)
KR (1)	KR101328851B1 (sr)
CN (2)	CN103169947B (sr)
AR (2)	AR063263A1 (sr)
AU (1)	AU2007306075B2 (sr)
BR (1)	BRPI0715317B1 (sr)
CA (1)	CA2666344C (sr)
CL (1)	CL2007002931A1 (sr)
CO (1)	CO6400235A2 (sr)
CY (1)	CY1114716T1 (sr)
DK (1)	DK2078038T3 (sr)
EA (1)	EA015802B1 (sr)
ES (1)	ES2438727T3 (sr)
GE (1)	GEP20125531B (sr)
HR (1)	HRP20140052T1 (sr)
IL (1)	IL198075A (sr)
JO (1)	JO2963B1 (sr)
MA (1)	MA31062B1 (sr)
ME (2)	MEP12109A (sr)
MX (1)	MX343064B (sr)
MY (1)	MY148127A (sr)
NO (1)	NO342038B1 (sr)
NZ (1)	NZ576189A (sr)
PE (1)	PE20081184A1 (sr)
PL (1)	PL2078038T3 (sr)
PT (1)	PT2078038E (sr)
RS (1)	RS53172B (sr)
SI (1)	SI2078038T1 (sr)
TN (1)	TN2009000099A1 (sr)
TW (1)	TWI388333B (sr)
UA (1)	UA94477C2 (sr)
WO (1)	WO2008044109A1 (sr)
ZA (1)	ZA200902481B (sr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2008011559A2 (en)	2006-07-20	2008-01-24	University Of Rochester	Synthetic lung surfactant and use thereof
EP1997502A1 (en) *	2007-06-01	2008-12-03	CHIESI FARMACEUTICI S.p.A.	Reconstituted surfactants having improved properties
US8399406B2 (en) *	2009-06-05	2013-03-19	Chiesi Farmaceutici S.P.A.	Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
CN101948526B (zh) *	2010-09-02	2012-12-05	华东理工大学	一种肺泡表面活性蛋白质(sp-b和sp-c)的分离纯化方法
WO2013120058A2 (en) *	2012-02-09	2013-08-15	University Of Rochester	Novel sp-b & sp-c peptides, synthetic lung surfactants, and use thereof
US20130303726A1 (en)	2012-04-17	2013-11-14	Chiesi Farmaceutici S.P.A.	Method for the preparation of surfactant peptides
US9074018B2 (en)	2012-11-21	2015-07-07	Chiesi Farmaceutici S.P.A.	Reconstituted pulmonary surfactants
EP3393489B1 (en)	2015-12-17	2021-09-01	Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center	Synthetic lung surfactant with enhanced stability and effectiveness
CA3016810C (en)	2016-03-07	2024-04-02	Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center	Compositions and methods for administering ppar.gamma. agonists, surfactant peptides and phospholipids
BR112019003673A2 (pt)	2016-08-24	2019-05-21	Chiesi Farmaceutici S.P.A.	formulação farmacêutica, uso de uma formulação farmacêutica e método para evitar o aumento da viscosidade durante o armazenamento de uma formulação farmacêutica
US12606609B2 (en)	2020-01-28	2026-04-21	Chiesi Farmaceutici S.P.A.	Polypeptides having improved properties
WO2022082082A2 (en) *	2020-10-16	2022-04-21	Sherwood Russ Lehrman	Lung treatment compositions
WO2025024609A1 (en) *	2023-07-25	2025-01-30	Biosuperior Technology, Inc.	Polypeptides for lung surfactant compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH08512056A (ja) *	1993-06-30	1996-12-17	ジェネンテク・インコーポレイテッド	リポソームの製造法
IT1308180B1 (it) *	1999-02-12	2001-12-07	Chiesi Farma Spa	Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
US7065342B1 (en) *	1999-11-23	2006-06-20	Gofigure, L.L.C.	System and mobile cellular telephone device for playing recorded music
ITMI20021058A1 (it) *	2002-05-17	2003-11-17	Chiesi Farma Spa	Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1481665A1 (en) *	2003-05-30	2004-12-01	CHIESI FARMACEUTICI S.p.A.	Novel lipid mixtures for synthetic surfactants
WO2008011559A2 (en) *	2006-07-20	2008-01-24	University Of Rochester	Synthetic lung surfactant and use thereof
EP1997502A1 (en) *	2007-06-01	2008-12-03	CHIESI FARMACEUTICI S.p.A.	Reconstituted surfactants having improved properties
EP2022798A1 (en)	2007-08-09	2009-02-11	CHIESI FARMACEUTICI S.p.A.	Synthetic pulmonary surfactant peptides

2007
- 2007-09-28 PT PT78252129T patent/PT2078038E/pt unknown
- 2007-09-28 ES ES07825212.9T patent/ES2438727T3/es active Active
- 2007-09-28 AU AU2007306075A patent/AU2007306075B2/en active Active
- 2007-09-28 KR KR1020097007008A patent/KR101328851B1/ko active Active
- 2007-09-28 BR BRPI0715317-1A patent/BRPI0715317B1/pt active IP Right Grant
- 2007-09-28 CA CA2666344A patent/CA2666344C/en active Active
- 2007-09-28 DK DK07825212.9T patent/DK2078038T3/da active
- 2007-09-28 ME MEP-121/09A patent/MEP12109A/xx unknown
- 2007-09-28 HR HRP20140052TT patent/HRP20140052T1/hr unknown
- 2007-09-28 SI SI200731393T patent/SI2078038T1/sl unknown
- 2007-09-28 ZA ZA200902481A patent/ZA200902481B/xx unknown
- 2007-09-28 MX MX2009003638A patent/MX343064B/es active IP Right Grant
- 2007-09-28 NZ NZ576189A patent/NZ576189A/en unknown
- 2007-09-28 MY MYPI20091454A patent/MY148127A/en unknown
- 2007-09-28 CN CN201310053516.8A patent/CN103169947B/zh active Active
- 2007-09-28 EP EP07825212.9A patent/EP2078038B1/en active Active
- 2007-09-28 JP JP2009531932A patent/JP5405307B2/ja active Active
- 2007-09-28 EA EA200900373A patent/EA015802B1/ru unknown
- 2007-09-28 GE GEAP200711224A patent/GEP20125531B/en unknown
- 2007-09-28 CN CN2007800382767A patent/CN101522711B/zh active Active
- 2007-09-28 ME MEP-2016-20A patent/ME02326B/me unknown
- 2007-09-28 WO PCT/IB2007/002841 patent/WO2008044109A1/en not_active Ceased
- 2007-09-28 RS RS20140037A patent/RS53172B/sr unknown
- 2007-09-28 UA UAA200903082A patent/UA94477C2/ru unknown
- 2007-09-28 PL PL07825212T patent/PL2078038T3/pl unknown
- 2007-10-11 TW TW096137965A patent/TWI388333B/zh active
- 2007-10-11 CL CL200702931A patent/CL2007002931A1/es unknown
- 2007-10-11 AR ARP070104520A patent/AR063263A1/es not_active Application Discontinuation
- 2007-10-11 JO JO2007436A patent/JO2963B1/en active
- 2007-10-11 PE PE2007001375A patent/PE20081184A1/es active IP Right Grant
2009
- 2009-03-25 TN TN2009000099A patent/TN2009000099A1/fr unknown
- 2009-04-07 IL IL198075A patent/IL198075A/en active IP Right Grant
- 2009-04-08 CO CO09036247A patent/CO6400235A2/es not_active Application Discontinuation
- 2009-04-13 US US12/422,581 patent/US8183210B2/en active Active
- 2009-04-14 NO NO20091441A patent/NO342038B1/no unknown
- 2009-05-08 MA MA31854A patent/MA31062B1/fr unknown
2012
- 2012-04-10 US US13/443,164 patent/US9238058B2/en active Active
2013
- 2013-08-02 JP JP2013161238A patent/JP2013241449A/ja active Pending
- 2013-12-11 CY CY20131101121T patent/CY1114716T1/el unknown
2018
- 2018-11-05 AR ARP180103211A patent/AR113422A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP5405307B2 (ja)	2014-02-05
ES2438727T3 (es)	2014-01-20
US8183210B2 (en)	2012-05-22
WO2008044109A1 (en)	2008-04-17
CN103169947B (zh)	2014-10-29
CO6400235A2 (es)	2012-03-15
MY148127A (en)	2013-02-28
JP2010505937A (ja)	2010-02-25
JO2963B1 (en)	2016-03-15
UA94477C2 (ru)	2011-05-10
RS53172B (sr)	2014-06-30
CN103169947A (zh)	2013-06-26
BRPI0715317A2 (pt)	2013-07-09
MX2009003638A (es)	2009-04-22
EP2078038A1 (en)	2009-07-15
US20130079275A1 (en)	2013-03-28
KR101328851B1 (ko)	2013-11-14
CY1114716T1 (el)	2016-10-05
HK1185274A1 (en)	2014-02-14
CL2007002931A1 (es)	2008-03-24
IL198075A0 (en)	2011-08-01
AU2007306075A1 (en)	2008-04-17
HK1134497A1 (en)	2010-04-30
NO342038B1 (no)	2018-03-19
TW200824705A (en)	2008-06-16
KR20090083892A (ko)	2009-08-04
NZ576189A (en)	2011-09-30
IL198075A (en)	2016-04-21
DK2078038T3 (da)	2013-12-02
MA31062B1 (fr)	2010-01-04
MX343064B (es)	2016-10-24
ME02326B (me)	2016-06-20
CA2666344C (en)	2017-04-18
SI2078038T1 (sl)	2014-02-28
US20100004173A1 (en)	2010-01-07
TN2009000099A1 (en)	2010-08-19
PL2078038T3 (pl)	2014-05-30
CA2666344A1 (en)	2008-04-17
TWI388333B (zh)	2013-03-11
BRPI0715317B1 (pt)	2021-10-05
PT2078038E (pt)	2013-12-12
MEP12109A (en)	2011-12-20
HRP20140052T1 (hr)	2014-02-28
EA200900373A1 (ru)	2009-10-30
AR063263A1 (es)	2009-01-14
CN101522711A (zh)	2009-09-02
US9238058B2 (en)	2016-01-19
JP2013241449A (ja)	2013-12-05
CN101522711B (zh)	2013-11-13
NO20091441L (no)	2009-06-23
AR113422A2 (es)	2020-04-29
EA015802B1 (ru)	2011-12-30
EP2078038B1 (en)	2013-11-20
PE20081184A1 (es)	2008-09-26
ZA200902481B (en)	2010-07-28
AU2007306075B2 (en)	2012-08-09

Publication	Publication Date	Title
TN2009000099A1 (en)	2010-08-19	Reconstituted surfactants having improved properties
MX2009012675A (es)	2009-12-14	Tensioactivos reconstituidos que tienen propiedades mejoradas.
MY159464A (en)	2017-01-13	Reconstituted surfactant composition containing analogs of surfactant protein b (sp-b) and surfactant protein c (sp-c)
MX2010002716A (es)	2010-07-05	Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago.
IN2015DN02553A (sr)	2015-09-11
UA95235C2 (en)	2011-07-25	Glucagon-like-peptide-2 (glp-2) analogues
CO6180466A2 (es)	2010-07-19	Composiciones y metodos para diagnosticar y tratar cancer
WO2011150284A3 (en)	2012-05-24	Removal of serine proteases by treatment with finely divided silicon dioxide
WO2009010968A3 (en)	2009-05-28	Disease treatment via antimicrobial peptides or their inhibitors
WO2005058252A3 (en)	2006-08-31	Glp-1 pharmaceutical compositions
MX2021008131A (es)	2021-10-13	Metodos y composiciones para el tratamiento de la enfermedad de fabry.
WO2004074315A3 (en)	2004-11-25	Analogues of glp-1
EA201000161A1 (ru)	2010-08-30	Синтетические поверхностно-активные пептиды легких
WO2005074626A3 (en)	2007-09-13	Compositions, methods and uses for a novel family of peptides
TW200740456A (en)	2007-11-01	GLP-1 pharmaceutical compositions
AU2003251728A8 (en)	2004-01-19	Placental growth factor as a target for the treatment of osteoporosis
DE60118898D1 (de)	2006-05-24	Verwendung von rekombinantem lungensurfactant zur frühbehandlung von akuten lungenerkrankungen
CL2019003179A1 (es)	2020-03-06	Eliminación de serina proteasas por tratamiento con dióxido de silicio finamente dividido. (divisional solicitud 201203291)
WO2024173352A3 (en)	2024-10-24	Methods of treating cancer with a sirp1a-based chimeric protein
UA96003C2 (en)	2011-09-26	PHARMACEUTICAL COMPOSITION [Aib8,35]hGLP-1(7-36)NH2
DOP2009000265A (es)	2010-02-28	Polipeptidos, dominios variables de anticuerpos y antagonistas